SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Asherson, R. A.
Right arrow Articles by Cervera, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asherson, R. A.
Right arrow Articles by Cervera, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

'Primary', 'Secondary' and Other Variants of the Antiphospholipid Syndrome

Ronald A. Asherson

Systemic Autoimmune Diseases Research Unit, Department of Internal Medicine, Hospital Clinic, Barcelona, Spain

Ricard Cervera

Systemic Autoimmune Diseases Research Unit, Department of Internal Medicine, Hospital Clinic, Barcelona, Spain

Although the APS seen as a PAPS or accompanying SLE essentially manifests the same clinical features, there appears to be distinct differences in the two groups of patients which have been summarized in this article. Additionally, the fact that some patients with Sneddon's syndrome, Trousseau's syndrome, or even Addison's disease, may in reality be examples of aPL-related vascular occlusive events has opened new avenues, not only for identification of these patients, but also for more systematic therapeutic regimens.

Lupus, Vol. 3, No. 4, 293-298 (1994)
DOI: 10.1177/096120339400300417


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BMJ Case ReportsHome page
R. Cianci, A. Gigante, B. Barbano, A. Zaccaria, L. Polidori, F. Borghesi, L. Gasperini, D. Di Donato, and A. Amoroso
Multiple steno-obstructive vascular lesions and femoral superficial artery dissection in a young Caucasian male with antiphospholipid syndrome
BMJ Case Reports, May 12, 2009; 2009(may12_1): bcr1220081342 - bcr1220081342.
[Abstract] [Full Text]


Home page
LupusHome page
T Tarr, G Lakos, H P Bhattoa, Y Shoenfeld, G Szegedi, and E Kiss
Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients
Lupus, January 1, 2007; 16(1): 39 - 45.
[Abstract] [PDF]


Home page
LupusHome page
A-L Fauchais, M Lambert, D Launay, U Michon-Pasturel, V Queyrel, N Nguyen, M Hebbar, E Hachulla, B Devulder, and P-Y Hatron
Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 74 patients
Lupus, April 1, 2004; 13(4): 245 - 248.
[Abstract] [PDF]


Home page
LupusHome page
M V. Freitas, L M da Silva, N H. Deghaide, E A Donadi, and P Louzada-Junior
Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome?
Lupus, February 1, 2004; 13(2): 125 - 131.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
D Caccavo, F Del Porto, P Garzia, A P Mitterhofer, S Galluzzo, A Rigon, M Vadacca, M F Navajas, A Amoroso, and A Afeltra
Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
Ann Rheum Dis, October 1, 2003; 62(10): 1003 - 1005.
[Abstract] [Full Text]


Home page
LupusHome page
P Soltesz, K Veres, G Lakos, E Kiss, L Muszbek, and G Szegedi
Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients
Lupus, April 1, 2003; 12(4): 302 - 307.
[Abstract] [PDF]


Home page
Mayo Clin Proc.Home page
H. G. Bulckaen, F. L. Puisieux, E. D. Bulckaen, C. Di Pompeo, O. M. Bouillanne, A. A. Watel, A.-L. M. Fauchais, P. De Groote, and A. Millaire
Antiphospholipid Antibodies and the Risk of Thromboembolic Events in Valvular Heart Disease
Mayo Clin. Proc., March 1, 2003; 78(3): 294 - 298.
[Abstract] [PDF]


Home page
LupusHome page
B Salobir, M Sabovic, and M Kozelj
Increased levels of antiphospholipid antibodies in a woman with left atrial myxoma and systemic embolisms
Lupus, November 1, 2001; 10(11): 815 - 817.
[Abstract] [PDF]


Home page
LupusHome page
Y. Sherer, A. Livneh, Y. Levy, Y. Shoenfeld, and P. Langevitz
Dermatomyositis and polymyositis associated with the antiphospholipid syndrome--a novel overlap syndrome
Lupus, January 1, 2000; 9(1): 42 - 46.
[Abstract] [PDF]


Home page
LupusHome page
A A Turjanski, J D Finkielman, and M Vazquez-Blanco
Isolated tricuspid valve disease in antiphospholipid syndrome
Lupus, July 1, 1999; 8(6): 474 - 476.
[Abstract] [PDF]


Home page
NEJMHome page
M. J. Landzberg, D. J. Roberts, and E. J. Mark
Case 4-1999- A 38-Year-Old Woman with Increasing Pulmonary Hypertension after Delivery
N. Engl. J. Med., February 11, 1999; 340(6): 455 - 464.
[Full Text] [PDF]


Home page
LupusHome page
A Gedalia, J F Molina, C O Garcia, S Doggett, L R Espinoza, and A E Gharavi
Anticardiolipin antibodies in childhood rheumatic disorders
Lupus, October 1, 1998; 7(8): 551 - 553.
[Abstract] [PDF]


Home page
CirculationHome page
M. Hojnik, J. George, L. Ziporen, and Y. Shoenfeld
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome
Circulation, April 15, 1996; 93(8): 1579 - 1587.
[Abstract] [Full Text]



Advertisement